09/16/2025 3:30 PM | Abate Kristin (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2025 3:31 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2025 3:32 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2025 3:33 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2025 3:34 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2025 3:35 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2025 3:33 PM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/04/2025 3:53 PM | Abate Kristin (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2025 11:12 AM | Karyopharm Therapeutics (Subject) T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G | |
08/11/2025 7:01 AM | Karyopharm Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/11/2025 6:31 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
08/11/2025 6:34 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/30/2025 3:56 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/23/2025 4:18 PM | Abate Kristin (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2025 8:34 AM | JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by) Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/11/2025 6:28 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/29/2025 3:28 PM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/29/2025 3:12 PM | Karyopharm Therapeutics (Issuer) Oliger Christy J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2025 3:13 PM | Karyopharm Therapeutics (Issuer) PAKIANATHAN DEEPIKA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2025 3:15 PM | Karyopharm Therapeutics (Issuer) Su Zhen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2025 3:40 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/14/2025 7:24 AM | Karyopharm Therapeutics (Filer)
| Form ARS | |
04/14/2025 7:15 AM | Karyopharm Therapeutics (Filer)
| Form DEF 14A | |
04/14/2025 7:19 AM | Karyopharm Therapeutics (Filer)
| Form DEFA14A | |
04/10/2025 4:23 PM | Affinity Asset Advisors, LLC (Filed by) Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/06/2025 3:13 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 3:48 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 3:49 PM | Abate Kristin (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 3:46 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2025 6:32 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/19/2025 6:36 AM | Karyopharm Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/12/2025 8:36 AM | Adage Capital Management, L.P. (Filed by) Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/05/2025 3:16 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 7:34 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/07/2025 3:03 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 4:07 PM | Karyopharm Therapeutics (Issuer) Macomber Lori (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2025 6:08 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2024 3:35 PM | Karyopharm Therapeutics (Filer)
| Form PRE 14A | |
12/05/2024 3:15 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 6:09 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2024 2:50 PM | Karyopharm Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
|
11/06/2024 3:06 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2024 7:02 AM | Karyopharm Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/05/2024 6:47 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024 6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 10:49 AM | Karyopharm Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/31/2024 6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2024 8:30 AM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) Karyopharm Therapeutics (Subject)
| Form SC 13G | |